AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CSL LIMITED

251.130

+5.7002.32%

Volume:1.26M

Turnover:315.98M

Market Cap:121.60B

PE:28.37

High:251.130

Open:246.000

Low:245.500

Close:245.430

Loading ...

Overview Company News Filings

Australia's CSL evaluates China tariff exemptions for its US-made drugs

The ultimate blue chip portfolio: 3 ASX 200 stocks to anchor your investments

CSL Unit, US Partner Say European Commission Grants Marketing Authorization for Kidney Disease Treatment Drug

MT Newswires Live

CSL Unit Awarded Contract by EU Regulator to Reserve 27 Million Flu Vaccine Doses

MT Newswires Live

How to turn $100 a week into $500,000 with ASX shares

Travere, CSL Vifor Receive EU Marketing Approval for Filspari in IgA Nephropathy

MT Newswires Live

BRIEF-Csl Seqirus Signs Agreement With The European Commission To Support Pandemic Preparedness Plans

CSL Ltd - CSL Seqirus Signs Agreement With the European Commission to Support Pandemic Preparedness Plans

THOMSON REUTERS

Brokers tip 4 ASX 200 healthcare shares to buy now

BRIEF-CSL Vifor And Travere Therapeutics Announce Standard EU Approval For Filspari® In Iga Nephropathy

CSL Vifor and Travere Therapeutics Announce Standard EU Approval for Filspari® in Iga Nephropathy

THOMSON REUTERS

3 ASX stocks with significant US exposure

3 ASX 200 stocks to buy and hold forever without thinking twice

How Trump's tariffs have created 'upside potential' for CSL shares

Why buy and hold investing with ASX shares could be your smartest move yet

The 2025 stock market selloff could be a once-in-a-decade opportunity to build wealth

3 oversold ASX shares begging to rebound

Warren Buffett's warning to markets played out perfectly: the time to be greedy may be approaching

West Pharmaceutical CFO Bernard Birkett to Retire

MT Newswires Live

What would Warren Buffett do with ASX shares right now?

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CSL.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CSL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","market":"AU","secType":"STK","nameCN":"CSL LIMITED","latestPrice":251.13,"timestamp":1745993520000,"preClose":245.43,"halted":0,"volume":1262608,"delay":0,"nameEN":"CSL LIMITED","floatShares":483950454,"shares":484212123,"eps":8.85093849200457,"marketStatus":"Not Yet Opened","change":5.7,"latestTime":"04-30 16:12:00 AEST","open":246,"high":251.13,"low":245.5,"amount":315981592,"amplitude":0.022939,"askPrice":251.24,"askSize":50,"bidPrice":250,"bidSize":4,"shortable":3,"etf":0,"ttmEps":8.85093849200457,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1746057600000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":245.43,"dividendRate":0.017164,"openAndCloseTimeList":[[1745971200000,1745992800000]],"volumeRatio":1.423339,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","floatShares":483950454,"roa":"6.69%","roe":"14.35%","lyrEps":8.549282,"volumeRatio":1.423339,"shares":484212123,"dividePrice":4.31035,"high":251.13,"amplitude":0.022939,"preClose":245.43,"low":245.5,"week52Low":228.61,"pbRate":"4.19","psRate":"5.11","week52High":308.856,"institutionHeld":0,"latestPrice":251.13,"committee":-0.851852,"eps":8.85093849200457,"divideRate":0.017164,"volume":1262608,"delay":0,"ttmEps":8.85093849200457,"open":246,"prevYearClose":279.35,"prevWeekClose":241.89,"prevMonthClose":249.28,"prevQuarterClose":249.28,"fiveDayClose":236.56,"twentyDayClose":252.72,"sixtyDayClose":278.21},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CSL.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2531876730","title":"Australia's CSL evaluates China tariff exemptions for its US-made drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2531876730","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531876730?lang=en_us&edition=fundamental","pubTime":"2025-04-30 18:17","pubTimestamp":1746008273,"startTime":"0","endTime":"0","summary":"SHANGHAI  -Australia's CSL Ltd said it's evaluating whether its drugs used in surgery would be exempted from 125% tariffs China imposed on U.S.-made goods, as it seeks to minimise impact of a trade war between Beijing and Washington.China has granted tariff exemptions on select products, including select pharmaceuticals, and has also created a non-public list of goods that would be exempted from duties, Reuters reported earlier on Wednesday, in the clearest sign yet of Beijing's concerns about the trade war's fallout.The quiet approach allows Beijing, which has repeatedly said it is willing to fight until the end unless the U.S. lifts its 145% tariffs on Chinese imports, to maintain its public messaging while privately taking practical steps to provide concessions.\"We are aware of reports that certain goods imported from the U.S. into China are potentially being exempted from tariffs,\" a spokesperson for CSL told Reuters in a statement.\"We are working to determine the potential for our","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/australias-csl-evaluates-china-tariff-101753571.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["XAO.AU","LU1169590202.USD","BK7067","BK4086","LU0728928796.USD","SGXZ23171101.USD","XJO.AU","BK7508","CSL.AU","XKO.AU","BK7501","CSL","BK7511","SG9999004303.SGD","LU1169589451.USD"],"gpt_icon":0},{"id":"2531872719","title":"The ultimate blue chip portfolio: 3 ASX 200 stocks to anchor your investments","url":"https://stock-news.laohu8.com/highlight/detail?id=2531872719","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531872719?lang=en_us&edition=fundamental","pubTime":"2025-04-30 11:46","pubTimestamp":1745984811,"startTime":"0","endTime":"0","summary":"If you're building a long-term investment portfolio, it can pay to start with the best. ASX 200 blue chip stocks — the large, established companies with strong track records and durable earnings — off","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/30/the-ultimate-blue-chip-portfolio-3-asx-200-stocks-to-anchor-your-investments/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["WOW.AU","BK4504","BK4127","XAO.AU","BK7002","LU0251142724.SGD","LU1868836757.USD","LU2471134952.CNY","LU2237443382.USD","XKO.AU","LU1791807156.HKD","LU0048573561.USD","BK4516","LU1868836591.USD","BK4550","BK4533","LU2750360997.AUD","IE0034235188.USD","LU1868837136.USD","LU2471134523.USD","LU2750360641.GBP","LU2237443622.USD","LU2237438978.USD","BK4585","BK4588","LU2471134879.HKD","BK7040","REA.AU","IE00BFXG1179.USD","LU2237443465.HKD","IE0004091025.USD","IE00BSNM7G36.USD","BK7067","XJO.AU","LU1868837300.USD","LU0061475181.USD","LU2237443978.SGD","LU0742534661.SGD","LU2471134796.USD","IE00B19Z3B42.SGD","LU0096364046.USD","LU2237443895.HKD","IE00B19Z3581.USD","LU0106831901.USD","BK7501","CSL.AU","IE0002270589.USD","LU1868836914.USD","LU0251131958.USD","BK7511"],"gpt_icon":0},{"id":"2531774643","title":"CSL Unit, US Partner Say European Commission Grants Marketing Authorization for Kidney Disease Treatment Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2531774643","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531774643?lang=en_us&edition=fundamental","pubTime":"2025-04-30 08:57","pubTimestamp":1745974653,"startTime":"0","endTime":"0","summary":"CSL's  Switzerland-based pharmaceutical unit, CSL Vifor, and US biopharmaceutical firm Travere Therapeutics said the European Commission has granted standard marketing authorization for Filspari, a treatment for primary IgA nephropathy , a rare and progressive kidney disease, according to a Tuesday statement by the company.The decision converts a previous conditional marketing authorization and extends to all European Union member states, as well as Iceland, Liechtenstein, and Norway, the company said.Filspari was developed by Travere Therapeutics and exclusively licensed to CSL Vifor for commercialization in Europe, Australia, and New Zealand.CSL's shares rose 1% in recent Wednesday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","LU1169590202.USD","SG9999004303.SGD","LU1169589451.USD","BK7501","BK7067","CSL","SGXZ23171101.USD","BK7511","BK4086","CSL.AU","LU0728928796.USD"],"gpt_icon":0},{"id":"2531774308","title":"CSL Unit Awarded Contract by EU Regulator to Reserve 27 Million Flu Vaccine Doses","url":"https://stock-news.laohu8.com/highlight/detail?id=2531774308","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531774308?lang=en_us&edition=fundamental","pubTime":"2025-04-30 08:31","pubTimestamp":1745973088,"startTime":"0","endTime":"0","summary":"CSL  said Tuesday CSL Seqirus was awarded a contract by the Health Emergency Preparedness and Response Authority to support the pandemic preparedness plans of 17 European Union and European Economic Area member states as well as the European Commission.Under the contract, 27 million doses of pandemic influenza vaccine have been reserved with CSL Seqirus, which can be ordered by the participating countries in the event of an influenza pandemic, according to a statement.The deal requires CSL Seqirus to be prepared to rapidly manufacture and deliver these vaccine doses. The doses will be produced at the company's manufacturing site in Liverpool, UK.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SGXZ23171101.USD","LU1169589451.USD","BK7067","BK7501","BK7511","LU0728928796.USD","LU1169590202.USD","CSL","CSL.AU","BK4086","SG9999004303.SGD","BK4156","BK7508"],"gpt_icon":0},{"id":"2531071038","title":"How to turn $100 a week into $500,000 with ASX shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2531071038","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531071038?lang=en_us&edition=fundamental","pubTime":"2025-04-30 06:15","pubTimestamp":1745964914,"startTime":"0","endTime":"0","summary":"Investing can seem daunting at first — especially if you're starting small. But here's the good news: you don't need a huge salary, a stock-picking superpower, or perfect timing to build serious wealt","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/30/how-to-turn-100-a-week-into-500000-with-asx-shares/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["VGS.AU","BK7503","BK7508","BK7041","BK7016","RMD.AU","BK7501","BK7153","WTC.AU","CSL.AU","IVV.AU","WES.AU","BK7511","BK7067","BK7007"],"gpt_icon":0},{"id":"2531512517","title":"Travere, CSL Vifor Receive EU Marketing Approval for Filspari in IgA Nephropathy","url":"https://stock-news.laohu8.com/highlight/detail?id=2531512517","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531512517?lang=en_us&edition=fundamental","pubTime":"2025-04-29 22:51","pubTimestamp":1745938294,"startTime":"0","endTime":"0","summary":"Travere Therapeutics (TVTX) and CSL Vifor said Tuesday that the European Commission has converted the conditional marketing approval of Filspari into a standard marketing authorization for the treatme","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1169590202.USD","LU1169589451.USD","SGXZ23171101.USD","TVTX","BK4086","BK7501","BK7067","BK7511","CSL.AU","CSL","SG9999004303.SGD","BK4156","BK4139","BK7508","LU0728928796.USD"],"gpt_icon":0},{"id":"2531769785","title":"BRIEF-Csl Seqirus Signs Agreement With The European Commission To Support Pandemic Preparedness Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2531769785","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531769785?lang=en_us&edition=fundamental","pubTime":"2025-04-29 18:58","pubTimestamp":1745924321,"startTime":"0","endTime":"0","summary":"BRIEF-Csl Seqirus Signs Agreement With The European Commission To Support Pandemic Preparedness PlansApril 29  - CSL Ltd CSL.AX:CSL SEQIRUS SIGNS  AGREEMENT WITH THE EUROPEAN COMMISSION TO SUPPORT PANDEMIC PREPAREDNESS PLANSFurther company coverage: CSL.AX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nFWN3R70YW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7508","CSL.AU","BK7501","BK7511"],"gpt_icon":0},{"id":"2531120074","title":"CSL Ltd - CSL Seqirus Signs  Agreement With the European Commission to Support Pandemic Preparedness Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2531120074","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531120074?lang=en_us&edition=fundamental","pubTime":"2025-04-29 18:30","pubTimestamp":1745922653,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nFWN3R70YW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7508","BK7501","BK7511","CSL.AU"],"gpt_icon":0},{"id":"2531227449","title":"Brokers tip 4 ASX 200 healthcare shares to buy now","url":"https://stock-news.laohu8.com/highlight/detail?id=2531227449","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531227449?lang=en_us&edition=fundamental","pubTime":"2025-04-29 15:05","pubTimestamp":1745910347,"startTime":"0","endTime":"0","summary":"ASX 200 healthcare shares finished in the green on Tuesday, with the S&P/ASX 200 Health Care Index  lifting 0.61%.  Healthcare is seen as a defensive sector.  In today's turbulent market, perhaps you might be looking for buying opportunities?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/29/brokers-tip-4-asx-200-healthcare-shares-to-buy-now/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["RMD.AU","CSL.AU","BK7501","BK7067","BK7007","BK7508","BK7511","HLS.AU","BK7124","TLX.AU","BK7509"],"gpt_icon":0},{"id":"2531225933","title":"BRIEF-CSL Vifor And Travere Therapeutics Announce Standard EU Approval For Filspari® In Iga Nephropathy","url":"https://stock-news.laohu8.com/highlight/detail?id=2531225933","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531225933?lang=en_us&edition=fundamental","pubTime":"2025-04-29 14:04","pubTimestamp":1745906694,"startTime":"0","endTime":"0","summary":"BRIEF-CSL Vifor And Travere Therapeutics Announce Standard EU Approval For Filspari In Iga NephropathyApril 29 (Reuters) - CSL Ltd CSL.AX:CSL VIFOR AND TRAVERE THERAPEUTICS ANNOUNCE STANDARD EU APPROV","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nFWN3R62E1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","TVTX","BK7508","BK7067","BK7501","BK7511","BK4139"],"gpt_icon":0},{"id":"2531225879","title":"CSL Vifor and Travere Therapeutics Announce Standard EU Approval for Filspari® in Iga Nephropathy","url":"https://stock-news.laohu8.com/highlight/detail?id=2531225879","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531225879?lang=en_us&edition=fundamental","pubTime":"2025-04-29 14:01","pubTimestamp":1745906478,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nFWN3R62E1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","CSL.AU","TVTX","BK4139","BK7511","BK7501","BK7508"],"gpt_icon":0},{"id":"2531950282","title":"3 ASX stocks with significant US exposure","url":"https://stock-news.laohu8.com/highlight/detail?id=2531950282","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531950282?lang=en_us&edition=fundamental","pubTime":"2025-04-29 06:57","pubTimestamp":1745881064,"startTime":"0","endTime":"0","summary":"Wrapping your head around investing can take a little bit of time. One important factor is that some ASX stocks are influenced by international economies such as the US. For example, industries like t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/29/3-asx-stocks-with-significant-us-exposure/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["LU2347655156.SGD","LU2111349929.HKD","LU2750360641.GBP","LU1668664300.SGD","IE0004086264.USD","LU1074936037.SGD","LU2471134879.HKD","RWC.AU","CSL.AU","LU2750360997.AUD","LU2237443549.SGD","LU0225283273.USD","LU2237443465.HKD","BK4581","LU0971096721.USD","LU1868836591.USD","LU0106831901.USD","LU1868836757.USD","LU0158827948.USD","BK4534","LU1720051108.HKD","LU1548497426.USD","LU0251131958.USD","BK4516","BK4533","IE00BZ1G4Q59.USD","LU2237443622.USD","LU1791807156.HKD","IE0002270589.USD","LU1868836914.USD","BK4585","BK7511","LU0742534661.SGD","LU0048573561.USD","BK4552","LU2237443978.SGD","IE00BFXG1179.USD","CTD.AU","IE00BKVL7J92.USD","IE0034235188.USD","IE00B19Z3B42.SGD","LU0096364046.USD","LU0795875086.SGD","LU2089283258.USD","LU2271345857.HKD","LU1720051017.SGD","LU2028103732.USD","BK4588","BK4504","LU2471134523.USD"],"gpt_icon":0},{"id":"2531296883","title":"3 ASX 200 stocks to buy and hold forever without thinking twice","url":"https://stock-news.laohu8.com/highlight/detail?id=2531296883","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531296883?lang=en_us&edition=fundamental","pubTime":"2025-04-29 05:52","pubTimestamp":1745877144,"startTime":"0","endTime":"0","summary":"When it comes to building lasting wealth, few strategies are as powerful — or as simple — as buy and hold investing. Instead of trying to time the market or jump in and out of ASX 200 stocks based on ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/29/3-asx-200-stocks-to-buy-and-hold-forever-without-thinking-twice/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4588","IE00B19Z3B42.SGD","LU2750360641.GBP","IE0004091025.USD","BK4585","BK7503","LU1868836591.USD","LU2237443978.SGD","BK7067","LU2237443622.USD","BK4127","BK4533","LU0096364046.USD","BK4550","LU2471134952.CNY","LU0742534661.SGD","LU1868836914.USD","WTC.AU","LU2471134523.USD","BK7511","BK4504","IE00B19Z3581.USD","BK4552","LU1791807156.HKD","LU1868837136.USD","LU2237443465.HKD","LU1868837300.USD","LU2237438978.USD","CSL.AU","IE0004086264.USD","LU2471134796.USD","LU2471134879.HKD","LU0106831901.USD","LU1668664300.SGD","LU1868836757.USD","LU2750360997.AUD","BK4516","LU0251131958.USD","BK7508","LU0048573561.USD","IE00BSNM7G36.USD","LU0251142724.SGD","BK7094","PME.AU","IE0002270589.USD","BK7501","LU2237443549.SGD","IE0034235188.USD","LU0061475181.USD","IE00BFXG1179.USD"],"gpt_icon":0},{"id":"2531926812","title":"How Trump's tariffs have created 'upside potential' for CSL shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2531926812","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531926812?lang=en_us&edition=fundamental","pubTime":"2025-04-29 02:30","pubTimestamp":1745865000,"startTime":"0","endTime":"0","summary":"CSL Ltd (ASX: CSL) shares have gone backwards over the past year. Shares in the S&P/ASX 200 Index(ASX: XJO) biotech stock closed up 0.99% on Monday trading for $244.29. Despite that welcome boost, sha","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/29/how-trumps-tariffs-have-created-upside-potential-for-csl-shares/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7067","LU1169590202.USD","SGXZ23171101.USD","BK4086","BK7508","CSL.AU","CSL","LU0728928796.USD","BK7501","SG9999004303.SGD","XJO.AU","LU1169589451.USD","BK7511"],"gpt_icon":0},{"id":"2530117461","title":"Why buy and hold investing with ASX shares could be your smartest move yet","url":"https://stock-news.laohu8.com/highlight/detail?id=2530117461","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530117461?lang=en_us&edition=fundamental","pubTime":"2025-04-27 05:15","pubTimestamp":1745702100,"startTime":"0","endTime":"0","summary":"Not every company is worthy of a permanent spot in your portfolio. Investors may want to look for ASX shares with a strong competitive advantage. Does the company have something special that is hard for rivals to replicate?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/27/why-buy-and-hold-investing-with-asx-shares-could-be-your-smartest-move-yet/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7082","CSL.AU","CBA.AU","BK7135","WES.AU","BK7501","BK7040","COL.AU","BK7041","BK7153","BK7067","BK7508","BK7511"],"gpt_icon":0},{"id":"2530763116","title":"The 2025 stock market selloff could be a once-in-a-decade opportunity to build wealth","url":"https://stock-news.laohu8.com/highlight/detail?id=2530763116","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530763116?lang=en_us&edition=fundamental","pubTime":"2025-04-26 09:30","pubTimestamp":1745631004,"startTime":"0","endTime":"0","summary":"They say history doesn't repeat itself, but it often rhymes—and right now, the ASX is humming a very familiar tune. The kind seasoned investors know as a rare and powerful signal: opportunity. After c","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/26/the-2025-stock-market-selloff-could-be-a-once-in-a-decade-opportunity-to-build-wealth/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["GMG.AU","MQG.AU","BK7510","BK7508","BK7511","TNE.AU","BK7503","QLTY.AU","CSL.AU","BK7155","IVV.AU","BK7046","BK7016","BK7099","BK7501","BK7067"],"gpt_icon":0},{"id":"2530919288","title":"3 oversold ASX shares begging to rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=2530919288","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530919288?lang=en_us&edition=fundamental","pubTime":"2025-04-26 06:35","pubTimestamp":1745620500,"startTime":"0","endTime":"0","summary":"The market has been serving up a fair amount of volatility lately, and in the rush to de-risk portfolios, even some of the highest quality ASX shares have been dragged lower. But as history often show","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/26/3-oversold-asx-shares-begging-to-rebound/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["IE00B19Z3B42.SGD","BK7503","CSL.AU","BK7067","IE0004091025.USD","BK7508","LU0096364046.USD","IE00BSNM7G36.USD","LU1868836757.USD","BK7511","LU1668664300.SGD","BK4504","LU0251142724.SGD","BK4588","LU2237443549.SGD","BK4516","BK4552","LU1868837300.USD","LU2471134879.HKD","LU2750360997.AUD","LU2237443895.HKD","BK7094","LU2471134796.USD","BK4550","LU2750360641.GBP","LU2237443465.HKD","LU1868836591.USD","LU0251131958.USD","PME.AU","BK7501","LU2237443622.USD","LU0106831901.USD","LU0742534661.SGD","LU2471134952.CNY","IE0004086264.USD","BK4585","LU2237443382.USD","LU0061475181.USD","LU1791807156.HKD","IE00BFXG1179.USD","LU2237438978.USD","LU2471134523.USD","IE0002270589.USD","LU2237443978.SGD","BK4127","IE0034235188.USD","LU1868836914.USD","LU1868837136.USD","BK7016","WTC.AU"],"gpt_icon":0},{"id":"2530547992","title":"Warren Buffett's warning to markets played out perfectly: the time to be greedy may be approaching","url":"https://stock-news.laohu8.com/highlight/detail?id=2530547992","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530547992?lang=en_us&edition=fundamental","pubTime":"2025-04-25 04:33","pubTimestamp":1745526780,"startTime":"0","endTime":"0","summary":"For long-term investors, periods of volatility often mark the beginning—not the end—of a wealth-building opportunity. Many quality ASX shares, from stalwarts like biotech giant CSL Ltd  and investment bank Macquarie Group Ltd  to fast-growing disruptors like health imaging technology company Pro Medicus Ltd  and online furniture and homewares retailer Temple & Webster Group Ltd , are trading at sharp discounts to what investors were willing to pay just a matter of weeks ago. If you have ve been sitting on the sidelines, waiting for the perfect moment—this may be it. Not because anyone can pick a bottom, but because, as Buffett shows time and again, value appears when investors are being fearful. So, is it time to be greedy?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/25/warren-buffetts-warning-to-markets-played-out-perfectly-the-time-to-be-greedy-may-be-approaching/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["LU0154236417.USD","LU1074936037.SGD","LU0251142724.SGD","LU1363072403.SGD","LU0048573561.USD","BK4585","BK4534","BK7501","IE00B775SV38.USD","LU0417517546.SGD","BK4581","LU0256863811.USD","IE00BKDWB100.SGD","LU1571399168.USD","BRK.B","LU0742534661.SGD","BK7046","BK7094","LU0787776722.HKD","BK4533","IE00B1XK9C88.USD","MQG.AU","BK7511","PME.AU","LU1366333091.USD","LU0149725797.USD","BK7049","BK4550","CSL.AU","LU0640476718.USD","IE00BJLML261.HKD","IE00BK4W5L77.USD","IE00BWXC8680.SGD","LU0251131958.USD","LU0971096721.USD","BK4176","IE0034235303.USD","TPW.AU","IE00B3S45H60.SGD","IE00BK4W5M84.HKD","LU0648001328.SGD","LU0053666078.USD","LU0980610538.SGD","LU0234570918.USD","LU0683600562.USD","BK7508","IE000M9KFDE8.USD","LU0130102774.USD","BK4588","LU0234572021.USD"],"gpt_icon":1},{"id":"2529705932","title":"West Pharmaceutical CFO Bernard Birkett to Retire","url":"https://stock-news.laohu8.com/highlight/detail?id=2529705932","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529705932?lang=en_us&edition=fundamental","pubTime":"2025-04-24 22:18","pubTimestamp":1745504339,"startTime":"0","endTime":"0","summary":"West Pharmaceutical Services  said Thursday that Chief Financial Officer Bernard Birkett plans to retire later this year and that a search for his successor is underway.Birkett is expected to remain in the CFO role until a successor is appointed and will then serve as an advisor to support a smooth transition, the company said.West also said it appointed Shane Campbell as chief proprietary segment officer, starting May 5. Campbell most recently served as chief commercial officer of the construction materials business at Carlisle .Shares of West Pharmaceutical Services were down 3.5% in recent trading.Price: 210.50, Change: -7.68, Percent Change: -3.52","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0728928796.USD","CSL","IE00BFXG0V08.USD","SG9999004303.SGD","CSL.AU","IE00B64QTZ34.USD","BK4588","LU1169590202.USD","BK4121","BK4086","BK4504","WST","BK4585","SGXZ23171101.USD","BK7511","IE00BYQQ9H92.USD","BK7501","BK7067","BK7508","BK4567","LU1169589451.USD"],"gpt_icon":0},{"id":"2529569525","title":"What would Warren Buffett do with ASX shares right now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2529569525","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529569525?lang=en_us&edition=fundamental","pubTime":"2025-04-24 06:39","pubTimestamp":1745447963,"startTime":"0","endTime":"0","summary":"It is fair to say that there's been no shortage of fear on the market lately. Trade tensions, volatility, and headlines predicting the next recession have sent many investors running for the sidelines. But if there's one person who would see today's environment as ripe with opportunity, it is Warren Buffett. While the Oracle of Omaha doesn't typically invest in the ASX, his investment playbook is universal — and it is perfectly suited to moments like these. So, if Buffett were eyeing the ASX today, what might he do?He probably wouldn't even notice. His holding periods often span 20–30 years, and his performance has been built on patience, not prediction. That's a good reminder for any ASX investor. Foolish takeaway Warren Buffett may not be browsing the ASX boards, but his principles can still guide you through turbulent times. Buy quality, ignore the noise, and think long term. In fact, Buffett said it best when he said:  Opportunities come infrequently. When it rains gold, put out th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/04/24/what-would-warren-buffett-do-with-asx-shares-right-now/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4534","LU0053666078.USD","LU0980610538.SGD","LU1914381329.SGD","LU0234570918.USD","LU0683600562.USD","CSL.AU","LU0149725797.USD","IE00BKDWB100.SGD","LU0648001328.SGD","LU1363072403.SGD","IE00BJLML261.HKD","RMD.AU","IE00B775SV38.USD","LU0640476718.USD","LU1280957306.USD","TNE.AU","BK4581","BK7128","BK4588","BRK.B","BK4550","LU0130102774.USD","LU0787776722.HKD","LU0971096721.USD","BK4585","LU1074936037.SGD","IE000M9KFDE8.USD","LU0170899867.USD","BK4533","IE00B1XK9C88.USD","LU0742534661.SGD","IE00B3S45H60.SGD","IE0034235303.USD","LU0048573561.USD","LU0256863811.USD","BK7501","LU1571399168.USD","BK7511","IE00BK4W5L77.USD","LOV.AU","LU0154236417.USD","IE00BK4W5M84.HKD","IE00BWXC8680.SGD","BK7503","LU0417517546.SGD","LU0251131958.USD","BK7016","BK7067","BK7508"],"gpt_icon":1}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CSL.AU\",params:#limit:5,,,undefined,":[{"date":"2025-03-10","symbol":"CSL.AU","amount":1.3,"announcedDate":"2025-02-11","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-03-11","name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-09","payableDate":"2025-03-11","currency":"USD","dateTimestamp":1741525200000,"payDate":"2025-04-09"},{"date":"2025-02-11","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1739228400000,"name":null,"time":"","dateTimestamp":1739192400000,"actualEps":null},{"date":"2024-09-09","symbol":"CSL.AU","amount":1.45,"announcedDate":"2024-08-13","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-09-10","defaultRemindTime":1725840000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-10-02","payableDate":"2024-09-10","currency":"USD","dateTimestamp":1725804000000,"payDate":"2024-10-02"},{"date":"2024-08-13","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723507200000,"name":null,"time":"","dateTimestamp":1723471200000,"actualEps":null},{"date":"2024-03-11","symbol":"CSL.AU","amount":1.19,"announcedDate":"2024-02-13","type":"dividend","market":"AU","newRecordDate":"2024-03-12","defaultRemindTime":1710111600000,"name":"CSL 公司","recordDate":"2024-04-03","payableDate":"2024-03-12","currency":"USD","dateTimestamp":1710075600000,"payDate":"2024-04-03"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CSL.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-10","recordDate":"2020-09-11","paymentDate":"2020-10-09","value":1.469578,"currency":"AUD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-04-01","value":1.04,"currency":"USD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-30","value":1.062,"currency":"USD"},{"executeDate":"2022-03-07","recordDate":"2022-03-08","paymentDate":"2022-04-06","value":1.04,"currency":"USD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-10-05","value":1.062,"currency":"USD"}]}}